Lv21
158 积分 2024-02-29 加入
Design and Discovery of Preclinical Candidate LYG-409 as a Highly Potent and Selective GSPT1 Molecular Glue Degraders
15天前
已完结
Evaluation of anti-leukemic activity and underlying mechanisms of the novel GSPT1 degrader AB138 in acute myeloid leukemia
15天前
已完结
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
1个月前
已完结
Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads
5个月前
已完结
Methods to measure the intracellular concentration of unlabeled compounds within cultured cells using liquid chromatography/tandem mass spectrometry
8个月前
已完结
Bispecific antibody targeting both B7-H3 and PD-L1 exhibits superior antitumor activities
9个月前
已完结
Bispecific antibodies: a mechanistic review of the pipeline
9个月前
已完结
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
9个月前
已完结
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)
9个月前
已完结
Bispecific antibody targeting both B7-H3 and PD-L1 exhibits superior antitumor activities
10个月前
已完结
皖公网安备34019202002308
